Factors affecting outcomes in very low birth weight infants treated electively with nasal continuous positive airway pressure

Journal of Perinatology

Volumn 30, Issue 2, 2010, Pages 112-117

  Swietlinski, J ^a   Bachman, T ^b   Gajewska, E ^c   Bober, K ^d   Helwich, E ^e   Lauterbach, R ^f   Maruszewski, B ^a   Szczapa, J ^g   Skrzypek, M ^d  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e INSTITUTE OF MOTHER AND CHILD   (Poland)

^f JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^g POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Clinical study; Nasal continuous positive pressure ventilation; Noninvasive ventilation

Indexed keywords

ARTICLE; ASSISTED VENTILATION; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; ENCEPHALOMALACIA; GESTATIONAL AGE; HUMAN; INFANT; INTUBATION; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN MORTALITY; PATIENT SELECTION; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

BLOOD GAS ANALYSIS; CONTINUOUS POSITIVE AIRWAY PRESSURE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTUBATION, INTRATRACHEAL; POLAND; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS; TREATMENT FAILURE;

EID: 76449100283     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.135     Document Type: Article

References (17)

1. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284: 1333-1340.
2. Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M, et al., Members of the Vermont Oxford Network. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002; 110: 143-151.
3. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003; (2) Art. no.: CD000143.
4. Bachman TE, Marks NE, Rimensberger PC. Factors effecting adoption of new neonatal and pediatric respiratory technologies. Intensive Care Med 2008; 34(1): 174-178.
5. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 2000; 105: 1194-1201.
6. Kirchner L, Weninger M, Unterasinger L, Birnbacher R, Hayde M, Krepler R et al. Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years of experience with the Vermont Oxford Neonatal Network. J Perinat Med 2005; 33(1): 60-66.
7. Jonsson B, Katz-Salamon M, Faxelius G, Broberger U, Lagercrantz H. Neonatal care of very low birth weight infants in special-care units and neonatal intensive care units in Stockholm: early nasal continuous positive airway pressure verses ventilation: gains and losses. Acta Pediatr Suppl 1997; 419: 4-10.
8. Swietlinski J, Bober K, Gajewska E, Helwich E, Lauterbach R, Manowska M et al. Introduction of Infant Flow nasal continuous airway pressure as a standard of practice in Poland: the initial 2-year experience. Pediatr Crit Care Med 2007; 8: 109-114.
9. Subramaniam P, Henderson-Smart DJ, Davis PG. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev 2005; (3) Art. no.: CD001243.
10. Morely CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, for COIN Trial Investigators. Nasal CPAP or intubation at birth for very premature infants. N Engl J Med 2008; 358: 700:8.
11. Sandri F, Ancora G, Lanzoni A, Tagliabue P, Colnaghi M, Ventura M.L, on behalf of the Pneumonology Study Group of the Italian Society of Neonatology. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation multicentre randomized controlled clinical trial. Arch Dis in Child Fetal and Neonatal Ed 2004; 89: F394-F398.
12. Jegatheesan P, Keller RL, Hawgood S. Early variable-flow nasal continuous positive airway pressure in infants p1000 g at birth. J Perinatol 2006; 26: 189-196.
13. deKlerk AM, deKlerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J Paediatr Child Health 2001; 37: 161-167.
14. Ammari A, Suri M, Milisavljevic V, Sahni R, Bateman D, Sanocka U. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005; 147(3): 341-347.
15. Lim NL, Zulfiqar MA. Predictors of failure of nasal continuous positive airway pressure in treatment of preterm infants with respiratory distress syndrome. J Trop Pediatr 2000; 46(Suppl 3): 172-175.
16. Ho JJ, Subramaniam P, Henderson-Smart DJ, Davis PG. Continuous distending pressure for respiratory disrtress syndrome in preterm infants. Cochrane Database Syst Rev 2002; (2) Art. no. CD002271.
17. De Paoli AG, Davis PG, Faber B, Morley CJ. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev 2008; (Suppl 1): CD002977.